Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00773773
Recruitment Status : Active, not recruiting
First Posted : October 16, 2008
Last Update Posted : November 6, 2017
National Institutes of Health (NIH)
New York Presbyterian Hospital
Weill Medical College of Cornell University
State University of New York - Downstate Medical Center
New York University School of Medicine
Kings County Hospital
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : October 2018
  Estimated Study Completion Date : October 2018